These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12789044)

  • 1. Vaccination available.
    Eilertson L
    Nurs Manage; 2003 Jun; 34(6):9. PubMed ID: 12789044
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccines to Prevent Pneumococcal Community-Acquired Pneumonia.
    van Werkhoven CH; Huijts SM
    Clin Chest Med; 2018 Dec; 39(4):733-752. PubMed ID: 30390745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults.
    Nelson JC; Jackson M; Yu O; Whitney CG; Bounds L; Bittner R; Zavitkovsky A; Jackson LA
    Vaccine; 2008 Sep; 26(38):4947-54. PubMed ID: 18662735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community acquired pneumonia (CAP) in children in the new vaccination era.
    Murphy JF
    Ir Med J; 2015 Mar; 108(3):68. PubMed ID: 25876293
    [No Abstract]   [Full Text] [Related]  

  • 5. [An outhospital pneumonia in patients vaccined with"Pneumo-23': peculiarities of clinics, diagnostics and treatment].
    Shepelenko AF; Stepanchenko AV; Vorobets VG
    Voen Med Zh; 2008 Sep; 329(9):44-9. PubMed ID: 19048853
    [No Abstract]   [Full Text] [Related]  

  • 6. Pneumococcal vaccination in older adults.
    Marras TK
    N Engl J Med; 2003 Aug; 349(7):712-4; author reply 712-4. PubMed ID: 12924340
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recommendations for prevention of community-acquired pneumonia with bacteremia as the leading form of invasive pneumococcal infections in the population of people over 50 years of age and risk groups above 19 years of age].
    Albrecht P; Antczak A; Hryniewicz W; Skoczyńska A; Radzikowski A; Kedziora-Kornatowska K; Bernatowska E; Stompór T; Grodzicki T; Gyrczuk E; Imiela J; Jedrzejczak W; Windak A
    Pol Merkur Lekarski; 2014 Feb; 36(212):79-87. PubMed ID: 24720101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-acquired pneumonia: cause and care.
    Kohlhepp WC
    JAAPA; 2002 Apr; 15(4):14-6, 21-4, 27. PubMed ID: 12012584
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of infant pneumococcal conjugate vaccination on community acquired pneumonia hospitalization in all ages in the Netherlands.
    van Deursen AMM; Schurink-Van't Klooster TM; Man WH; van de Kassteele J; van Gageldonk-Lafeber AB; Bruijning-Verhagen PCJL; de Melker HE; Sanders EAM; Knol MJ
    Vaccine; 2017 Dec; 35(51):7107-7113. PubMed ID: 29146381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe pneumonia among Kenyan infants and children.
    Nascimento-Carvalho CM; Ruuskanen O
    JAMA; 2010 Sep; 304(9):963; author reply 964-5. PubMed ID: 20810371
    [No Abstract]   [Full Text] [Related]  

  • 11. Community-acquired pneumonia in children.
    McIntosh K
    N Engl J Med; 2002 Feb; 346(6):429-37. PubMed ID: 11832532
    [No Abstract]   [Full Text] [Related]  

  • 12. In brief: PCV13 for adults 65 years and older.
    Med Lett Drugs Ther; 2014 Oct; 56(1453):102. PubMed ID: 25296261
    [No Abstract]   [Full Text] [Related]  

  • 13. Review: In COPD, injectable polyvalent pneumococcal vaccines reduce risk for community-acquired pneumonia.
    Stanbrook MB
    Ann Intern Med; 2017 May; 166(10):JC52. PubMed ID: 28505636
    [No Abstract]   [Full Text] [Related]  

  • 14. Community-acquired pneumonia.
    Loeb M
    Am Fam Physician; 2002 Jul; 66(1):135-7. PubMed ID: 12126028
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of community-acquired pneumonia among a cohort of hospitalized elderly: benefit due to influenza and pneumococcal vaccination not demonstrated.
    Skull SA; Andrews RM; Byrnes GB; Kelly HA; Nolan TM; Brown GV; Campbell DA
    Vaccine; 2007 Jun; 25(23):4631-40. PubMed ID: 17478015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pneumococcal problem.
    Obaro SK; Monteil MA; Henderson DC
    BMJ; 1996 Jun; 312(7045):1521-5. PubMed ID: 8646147
    [No Abstract]   [Full Text] [Related]  

  • 17. Pneumococcus and the Elderly in Italy: A Summary of Available Evidence Regarding Carriage, Clinical Burden of Lower Respiratory Tract Infections and On-Field Effectiveness of PCV13 Vaccination.
    Orsi A; Ansaldi F; Trucchi C; Rosselli R; Icardi G
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving pneumococcal vaccination rates.
    Nace DA
    J Am Med Dir Assoc; 2003; 4(2):121-2. PubMed ID: 12807589
    [No Abstract]   [Full Text] [Related]  

  • 19. [Progress on the effectiveness of the pneumococcal vaccination in patients with chronic obstructive pulmonary disease].
    Wu YX; Zhang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Apr; 45(4):404-409. PubMed ID: 35381638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal vaccination for Indian children.
    Levine OS; Cherian T
    Indian Pediatr; 2007 Jul; 44(7):491-6. PubMed ID: 17684301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.